Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1999

Effect of estradiol and norethisterone replacement therapy on the pharmacokinetics of phenazone

Jerzy W—ójcicki, Igor Łoniewski, Jerzy Łokociejewski, Marek Drozdzik, Barbara Gawrońska-Szklarz

Med Sci Monit 1999; 5(4): PI754-757 :: ID: 504661

Abstract

The aim of this study was to determine whether short term replacement therapy with estradiol and norethisterone affect the pharmacokinetics of phenazone. The study group comprised of 10 women, aged between 38-62 years, at least six weeks following ovariectomy. Each patient received estradiol (transdermally, 4 mg plaster every 3 days) for a period of 18 days, and subsequently norethisterone (orally, 5 mg per day) for 10 days, with an interval of one day. Pharmacokinetic studies were performed 3 times: prior to estradiol administration, on the last day of estradiol treatment and on the last day of norethisterone administration. Pharmacokinetic assays were performed following a single, oral administration of phenazone at a dose of 1.0 g, followed by blood sampling fora period of 24 hours, in order to determine plasma phenazone concentration levels. Brodi's method was applied for the measurement of phenazone concentrations. The one-compartment open model for extravascular administration was used for the calculations of pharmacokinetic parameters. Short-term administration of estradiol did not significantly alter pharmacokinetic parameter valuess determined during the study. Hormonal replacement therapy with norethisterone does not modify the pharmacokinetics of phenazone. Hormonal replacement therapy with both estradiol and norethisterone does not affect the biotransformation of phenazone.

Keywords: phenazone pharmacokinetics, norethisterone, hormonal replacement therapy

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750